No consensus: Clinical trials wrestle with role of atropine in treating amblyopia
January 1st 2003Baltimore-Amblyopia is a relatively common problem in children, but there is no consensus on the best treatment. Recently, there has been increasing interest in using atropine drops instead of patching, but they are not FDA approved for that indication, said Michael X. Repka, MD.
Advances in macular surgery helpful for pathologic myopia disorders
January 1st 2003Orlando-Recent advances in macular surgery are now making it possible to treat the various disorders associated with pathologic myopia, according to Yasuo Tano, MD, who delivered the Edward Jackson Memorial Lecture during the opening session of the American Academy of Ophthalmology annual meeting.
Glaucoma drugs may pose risk to ocular surface
January 1st 2003Orlando-Ophthalmologists should be aware of the risks to the ocular surface associated with long-term use of glaucoma medications, according to Robert J. Noecker, MD, MBA, who also spoke at the Cornea Health symposium during the American Academy of Ophthalmology annual meeting.
Screen, treat ocular surface disease prior to cataract, refractive procedures
January 1st 2003Orlando-Pay attention to the ocular surface before undertaking a cataract or refractive procedure, advised John D. Sheppard, MD, who outlined strategies in his practice for avoiding surgical complications at the Cornea Health symposium held during the American Academy of Ophthalmology annual meeting.
Call for volunteers: Doctors needed to restore sight in developing nations
January 1st 2003Santa Barbara, CA-Volunteer ophthalmologists with Surgical Eye Expeditions International will visit 50 clinics in 32 developing countries to restore eyesight to disadvantaged patients with surgically correctable blindness during 2003.
CRYO-ROP 10-year follow-up finds continued benefit
December 15th 2002Long-term results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP study) are showing continued advantages for treatment in preventing blindness and no long-term disadvantage with reference to acuity.
Verhoeff, Reese were pioneers of ophthalmic oncology
December 15th 2002Pathology is the branch of medicine that deals with the nature of diseases, their cause and effect, particularly from the structural and functional changes that they cause. In its earliest forms, its origins date back to biblical times.
Ophthalmic prisms useful in management of tropias, phorias
December 15th 2002Asthenopia, blurred vision, and diplopia are classic symptoms of strabismus, which occasionally requires the use of prism or surgery to restore normal binocular vision. Ophthalmic prisms may be useful in the management of both tropias and phorias. In this column, we will discuss the management of prescriptions that contain prism.
Diffractive multifocal lens reduces halo complaints
December 15th 2002Nice, France-The diffractive/refractive, fold-able, multifocal AcrySof IOL (study model MA60D3, Alcon, Fort Worth, TX) achieves similar mean distance vision and better near vision compared with the Array multifocal SA40N IOL (AMO, Santa Ana, CA), an FDA-approved IOL. Importantly, patients reported significantly fewer complaints of halos compared with the SA40N IOL, according to Philippe Dublineau, MD.
EMGT finds lower IOP delays progression
December 15th 2002Malm?weden-The initial results of the Early Manifest Glaucoma Trial (EMGT), a National Eye Institute-sponsored study conducted in Sweden, suggest that IOP-lowering treatment significantly delays progression of open-angle glaucoma in patients with elevated and normal IOP.
Two-tipped LASIK tool gently breaks through epithelium
December 15th 2002The Castillejos LASIK re-treatment spatula (Rhein Medical Inc.)was designed to help surgeons lift stubborn flaps more easily, and with less trauma to theepithelium, according to the instrument's inventor, David Castillejos, MD, FACS.
Eye collection site moves to Cole Eye Institute
December 15th 2002Cleveland-Cleveland Clinic's Cole Eye Institute has been chosen as the Foundation Fighting Blindness' national collection site for eyes donated for blindness research. The collection center, formally known as the Retinal Degeneration Pathophysiology Facility, was previously located in Phila-delphia.
WHO report indicates value of better eye care
December 15th 2002Geneva-Visual impairment and blindness are taking a toll on poor countries in terms of lost productivity. About 80% of these cases could be prevented or treated, according to a report issued by the World Health Organization (WHO) and the International Agency for the Prevention of Blindness (IAPB).
Afghanistan's foreign minister calls for help from AAO members
December 15th 2002Orlando-Abdullah Abdullah, MD, the foreign minister of the transitional government of Afghanistan, asked members of the American Academy of Ophthalmology (AAO) to help his country in any way they could to improve the state of eye care for 22 million people.
New director named: ASCRS picks Don Bell to guide its foundation
December 15th 2002Fairfax, VA-Don Bell, who has spent 8 years handling membership, special projects, and program development with the American Society of Cataract and Refractive Surgery (ASCRS), takes on a new role as director of the ASCRS Foundation.
Use to widen: Prescription inserts see extended range in Europe
December 15th 2002Fremont, CA-Addition Technology Inc. will double its product line in Europe since it recently received a CE marking for six new sizes of Intacs prescription inserts. The new sizes extend the availability of the inserts in both smaller increments (0.275, 0.325, 0.375, and 0.425 mm) and new sizes (0.21 and 0.23 mm).